![Ekaterina Smirnyagina](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ekaterina Smirnyagina
Directeur/Membre du Conseil chez
ADOCIA
Profil
Ekaterina Smirnyagina is currently Director at European Private Equity & Venture Capital Association, Independent Director at Adocia SA since 2013, Director at Oxford Nanoimaging Ltd., Director at Spybiotech Ltd., and Senior Partner at Oxford Science Enterprises PLC since 2021.
Former positions include Executive Director Capricorn Health-tech Fund at Capricorn Partners NV from 2012 to 2021, Director roles at Ablynx NV, Nexstim Oyj, ABIONYX Pharma SA, Cerenis Therapeutics, Inc., iSTAR Medical SA, HalioDx SASU, Confo Therapeutics NV, MiroBio Ltd., and Invest Europe VZW.
Other former roles include Venture Partner at Alta Partners Management Co. LP from 2002 to 2012, Principal at Mitchell Madison Group LLC, Member-Supervisory Board at Innate Pharma SA, and Principal at Genset Corp.
Education includes a doctorate from the University of Wisconsin conferred in 1996 and an undergraduate degree from Moscow State University Lomonosov conferred in 1988.
Postes actifs de Ekaterina Smirnyagina
| Sociétés | Poste | Début |
|---|---|---|
| ADOCIA | Directeur/Membre du Conseil | 18/06/2013 |
Oxford Nanoimaging Ltd.
 Oxford Nanoimaging Ltd. Packaged SoftwareTechnology Services Develops and researches intelligent software and fluorescence microscopy image cells | Directeur/Membre du Conseil | - |
Oxford Science Enterprises PLC
 Oxford Science Enterprises PLC Investment ManagersFinance Oxford Science Enterprises invests in companies located in the United Kingdom. The firm targets companies operating in the fields of health tech, deep tech, and life sciences sectors. It provides financing for seed and early stage capital requirements with an investment size of GBP 0.1 – 10 million. | Private Equity Investor | 01/09/2021 |
European Private Equity & Venture Capital Association | Directeur/Membre du Conseil | - |
Spybiotech Ltd.
 Spybiotech Ltd. BiotechnologyHealth Technology Develops a molecular superglue which it believes can be used to create vaccines | Directeur/Membre du Conseil | - |
Anciens postes connus de Ekaterina Smirnyagina
| Sociétés | Poste | Fin |
|---|---|---|
Capricorn Partners NV
 Capricorn Partners NV Investment ManagersFinance Capricorn Partners invests in companies located in Europe. The firm focuses on sectors such as digital, health and clean technologies. It participates in early and growth stage capital transactions. | Private Equity Investor | 01/09/2021 |
Alta Partners Management Co. LP
 Alta Partners Management Co. LP Investment ManagersFinance Alta Partners invests in companies located in the United States. The firm focuses on life sciences and healthcare technology services sectors. It participates in seed, early and later stage capital transactions. It acts as the lead investor and takes a seat on board of directors. | Private Equity Investor | 01/09/2012 |
| ABLYNX | Directeur/Membre du Conseil | - |
Genset Corp.
 Genset Corp. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceuticals | Corporate Officer/Principal | - |
| ░░░░░░░░ ░░░░░░░ ░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de Ekaterina Smirnyagina
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
89
Relations au 1er degré
21
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 21 |
|---|---|
Alta Partners Management Co. LP
Alta Partners Management Co. LP Investment ManagersFinance Alta Partners invests in companies located in the United States. The firm focuses on life sciences and healthcare technology services sectors. It participates in seed, early and later stage capital transactions. It acts as the lead investor and takes a seat on board of directors. | Finance |
Capricorn Partners NV
Capricorn Partners NV Investment ManagersFinance Capricorn Partners invests in companies located in Europe. The firm focuses on sectors such as digital, health and clean technologies. It participates in early and growth stage capital transactions. | Finance |
Mitchell Madison Group LLC
 Mitchell Madison Group LLC Miscellaneous Commercial ServicesCommercial Services Provides global cost management consulting services | Commercial Services |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Moscow State University Lomonosov
 Moscow State University Lomonosov Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Innate Pharma SA
 Innate Pharma SA Pharmaceuticals: MajorHealth Technology Develops therapeutic antibodies that harness the immune system to improve cancer treatment and clinical outcomes | Health Technology |
Ablynx NV
 Ablynx NV BiotechnologyHealth Technology Develops and produces antibodies | Health Technology |
Nexstim Oyj
 Nexstim Oyj Medical SpecialtiesHealth Technology Develops non-invasive brain stimulation technology | Health Technology |
ABIONYX Pharma SA
 ABIONYX Pharma SA Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel HDL therapies for the treatment of cardiovascular and metabolic diseases | Health Technology |
Genset Corp.
Genset Corp. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceuticals | Health Technology |
European Private Equity & Venture Capital Association | |
Cerenis Therapeutics, Inc.
 Cerenis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes drugs | Health Technology |
Adocia SA
 Adocia SA Pharmaceuticals: MajorHealth Technology Manufactures novel therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases | Health Technology |
iSTAR Medical SA
 iSTAR Medical SA Medical SpecialtiesHealth Technology Develops innovative implants for eye care solutions | Health Technology |
HalioDx SASU
 HalioDx SASU BiotechnologyHealth Technology Engages in research and development of immuno-oncology diagnostics | Health Technology |
Oxford Science Enterprises PLC
Oxford Science Enterprises PLC Investment ManagersFinance Oxford Science Enterprises invests in companies located in the United Kingdom. The firm targets companies operating in the fields of health tech, deep tech, and life sciences sectors. It provides financing for seed and early stage capital requirements with an investment size of GBP 0.1 – 10 million. | Finance |
Confo Therapeutics NV
 Confo Therapeutics NV Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Oxford Nanoimaging Ltd.
Oxford Nanoimaging Ltd. Packaged SoftwareTechnology Services Develops and researches intelligent software and fluorescence microscopy image cells | Technology Services |
Spybiotech Ltd.
Spybiotech Ltd. BiotechnologyHealth Technology Develops a molecular superglue which it believes can be used to create vaccines | Health Technology |
MiroBio Ltd.
 MiroBio Ltd. BiotechnologyHealth Technology Develops therapeutics for auto-immune diseases | Health Technology |
Invest Europe VZW
 Invest Europe VZW Investment ManagersFinance Operates as a private equity, venture capital and infrastructure investment company | Finance |
